-
Mashup Score: 1Highlights from Digital ILC 2020 - 4 year(s) ago
Healio Gastroenterology presents some of the top stories from The Digital International Liver Congress 2020.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
In this exclusive video, Steven Flamm, MD, chief of the liver program at the Northwestern Feinberg School of Medicine, discusses a potential treatment for alcoholic hepatitis that is currently in development.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
In this exclusive video, Steven Flamm, MD, chief of the liver program at the Northwestern Feinberg School of Medicine, discusses a potential treatment for alcoholic hepatitis that is currently in development. #ILC2020 https://t.co/azqaAyS6zn
-
-
Mashup Score: 1Many Advanced Countries Missing Targets for HCV Elimination - 4 year(s) ago
The World Health Organization wants to eliminate hepatitis C infection by the end of the decade. Researchers performed disease progression models of HCV infection in 45 high-income countries.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
11 high-income countries are on track to meet @WHO #HepC elimination targets. 28 are not. https://t.co/z5g1jtofjg #ILC2020
-
-
Mashup Score: 0
Patients with hepatitis B treated with an investigational RNAi drug experienced reduced levels of surface antigens across different dose levels, according to research presented at The Digital International Liver Congress.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
From #ILC2020, patients with hepatitis B treated with an investigational RNAi drug experienced reduced levels of surface antigens across different dose levels. https://t.co/BnZdRarSCY
-
-
Mashup Score: 0VIDEO: No ‘hard-to-reach’ patients in HCV, just ‘hardly reached’ - 4 year(s) ago
In this exclusive video, Joss O’Loan, MBBS, from the Hepatitis C Kombi Clinic in Brisbane, Australia, discusses two studies presented at The Digital International Liver Congress on HCV elimination programs using Epclusa.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
We talked to, Joss O’Loan, MBBS, about two studies presented at #ILC2020 on HCV elimination programs using Epclusa. https://t.co/O3XHcoSsRu
-
-
Mashup Score: 2Fecal Transplant Shows Promise in Reducing Alcohol Craving - 4 year(s) ago
Fecal transplantation for end-stage cirrhosis improves microbiome diversity, reduces alcohol cravings, and improves quality of life, a new safety study shows.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Potentially viable treatment option for the world’s most common addiction disorder. https://t.co/Bs6LgcFAtf #ILC2020
-
-
Mashup Score: 7Fecal Transplant Shows Promise in Reducing Alcohol Craving - 4 year(s) ago
Fecal transplantation for end-stage cirrhosis improves microbiome diversity, reduces alcohol cravings, and improves quality of life, a new safety study shows.
Source: MedscapeCategories: Latest Headlines, PsychiatryTweet-
Potentially viable treatment option for the world’s most common addiction disorder. https://t.co/liSH234qhS #ILC2020
-
-
Mashup Score: 0Machine learning outperforms noninvasive tests in NAFLD - 4 year(s) ago
Machine learning may be a reasonable solution for screening for fatty liver in the general population in areas where more niche noninvasive tests are unavailable, according to a presenter at the Digital International Liver Congress.“Risk stratification is key to reducing unnecessary testing in liver disease screening. While transient elastography [TE] could be considered the noninvasive
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
Study out of Spain shows #machinelearning outperformed non-invasive tools to detect #fattyliver #ILC2020 https://t.co/qqoiNw3KnD
-
-
Mashup Score: 0
Fibroblast growth factor 19 analogue aldafermin showed dose- and duration-dependent reduction in liver fat with resolution of non-alcoholic steatohepatitis in more than one-fifth of cases, according to a presenter at the Digital International Liver Congress.“Ultimately, looking at the study from cohort 4, the primary endpoint was met. Clinically significant improvements in histology
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
Stephen Harrison @Pinnacle_TX shows promising results from #FGF19 aldafermin in treating #NASH, #fattyliver #ILC2020 https://t.co/usyTivxNXp
-
-
Mashup Score: 0COVID-19 in gastroenterology & hepatology - 4 year(s) ago
COVID-19 in gastroenterology & hepatology
Source: www.nature.comCategories: Gastroenterology, Latest HeadlinesTweet-
Great #ILC2020 session on #COVID19 & the liver [KR]. All our COVID19 articles are together in this Collection https://t.co/RjI4ZP2bsD includes these liver-specific ones *liver-related deaths to come https://t.co/hxX1Z9NpmC *liver transplantation https://t.co/Ik7zvPhADm
-
Here are some of our top articles and videos from #ILC2020 https://t.co/UBZBhWQgrz